KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bristol Myers Squibb (BMY) Return on Capital Employed (2016 - 2025)

Bristol Myers Squibb (BMY) has disclosed Return on Capital Employed for 15 consecutive years, with 0.12% as the latest value for Q1 2025.

  • On a quarterly basis, Return on Capital Employed changed N/A to 0.12% in Q1 2025 year-over-year; TTM through Mar 2025 was 0.12%, a N/A change, with the full-year FY2025 number at 0.07%, changed N/A from a year prior.
  • Return on Capital Employed was 0.12% for Q1 2025 at Bristol Myers Squibb, up from 0.32% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.02% in Q4 2021 to a low of 0.32% in Q4 2024.
  • A 4-year average of 0.09% and a median of 0.03% in 2022 define the central range for Return on Capital Employed.
  • Peak YoY movement for Return on Capital Employed: rose 16bps in 2021, then decreased -1bps in 2022.
  • Bristol Myers Squibb's Return on Capital Employed stood at 0.02% in 2021, then plummeted by -54bps to 0.03% in 2022, then plummeted by -905bps to 0.32% in 2024, then surged by 64bps to 0.12% in 2025.
  • Per Business Quant, the three most recent readings for BMY's Return on Capital Employed are 0.12% (Q1 2025), 0.32% (Q4 2024), and 0.03% (Q4 2022).